Skip to main content
SpringerLink
Log in

Multidrug Resistance Related Proteins in Primary Cutaneous Lymphomas

  • Chapter
Drug Resistance in Leukemia and Lymphoma III

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 457))

Abstract

In patients with primary cutaneous B-cell lymphomas (CBCL) and primary cutaneous T-cell lymphomas (CTCL), extracutaneous sites may become involved and then polychemotherapy is indicated. Multi-agent chemotherapy may induce long lasting complete remissions in CBCL’s. Most CTCL’s, especially mycosis fungoides (MF), and CD30 negative primary cutaneous large T-cell lymphoma (PCLTCL) respond poorly or partially to Multi-agent Chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Peréz JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, Van Vloten WA, Meijer CJLM. EORTC classification for primary cutaneous lymphomas: A proposal from the cutaneous lymphomas study group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90:354–71.

    PubMed  CAS  Google Scholar 

  2. Kay FJ, Bunn PA, Steinberg SM. A randomized trial comparing combination electron beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989; 321, 1784.

    Article  Google Scholar 

  3. Pui C, Relling MV, Mason E, Rivera GK, Crist WM, Evans WE. Pharmacokinetic resistance in childhood leukaemia. In: drug resistance in leukaemia and lymphoma II. Eds. R. Pieters, GJL Kaspers and AJP Veerman. Harwood Academic Publishers 1997 The Netherlands pp 1–7.

    Google Scholar 

  4. Rossi JF. Biological and clinical aspects of chemoresistance. Part 2: leukaemias. Retinoids today and tomorrow 1996; 45:28–31.

    Google Scholar 

  5. Yuen AR, Sikic BI. Multidrug resistance in lymphomas. J Clin Oncol 1994; 12:2453–2459.

    PubMed  CAS  Google Scholar 

  6. Landowski TH, Gleason-Guzman MC, Dalton WS. Selection for drug resistance results in resistance to fas-mediated apoptosis. Blood 1997; 89:1854–1861.

    PubMed  CAS  Google Scholar 

  7. den Boer ML, Zwaan MC, Pieters R, Kazemier KM, Rottier MMA, Flens MJ, Scheper RJ and Veerman AJ. Optimal immunocytochemical and flow cytometric detection of Pgp, MRP and LRP in childhood acute lymphoblastic leukemia. Leukemia 1997; 11:1078–1085.

    Article  Google Scholar 

  8. Marie JP. P-glycoprotein in adult hematologic malignancies. Hematology/oncology clinics of North-America 1995; 9:239–248.

    PubMed  CAS  Google Scholar 

  9. Legrand O, Perrot JY, Tang R, Simonin G, Gurbuxani S, Zittoun R, Marie JP. Expression of the multidrug resistance-associated protein (MRP) MRNA and protein in normal peripheral blood and bone marrow haemopoietic cells. Br J Haematol 1996; 94:23–33.

    Article  PubMed  CAS  Google Scholar 

  10. Flens MJ, Izquierdo MA, Scheffer GL, Fritz JM, Meijer CJLM, Scheper RJ and Zaman GJR. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res 1994; 54:4557–4563.

    PubMed  CAS  Google Scholar 

  11. Nooter K, Westerman MA, Flens MJ, Zaman GJR, Scheper RJ, van Wingerden KE, Burger H, Oostrum R, Boersma T, Sonneveld P, Gratema JW, Kok T, Eggermont AMM, Bosman FT and Stoter G. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin Cancer Res 1995; 147:1545–1552.

    Google Scholar 

  12. Flens MF, Zaman GJR, van der Valk P, Izquierdo MA, Schroeijers AB, Scheffer GL, van der Groep P, de Haas M, Meijer CJLM and Scheper RJ. Tissue distribution of the multidrug resistance protein. Am J Pathol 1996; 148:1237–1247.

    PubMed  CAS  Google Scholar 

  13. Zhan Z, Sandor VA, Gamelin E, Regis J, Dickstein B, Wilson W, Fojo AT, Bates SE. Expression of the multidrug resistance-associated protein gene in refractory lymphoma: Quantitation by a validated polymerase chain reaction assay. Blood 1997; 89:3795–3800.

    PubMed  CAS  Google Scholar 

  14. Izquierdo MA, Scheffer GL, Flens MF, Schroeijers AB, van der Valk P and Scheper RJ. Major vault protein LRP-related multidrug resistance. Eur J Cancer 1996; 32A: 979–984.

    Article  PubMed  CAS  Google Scholar 

  15. Izquierdo MA, Scheffer GL, Flens MJ, Giaccone G, Broxterman HJ, Meijer CJLM, van der Valk P and Scheper RJ. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am J Pathol 1996; 148:877–887.

    PubMed  CAS  Google Scholar 

  16. Wilson WH, Bates SE, Fojo A, Bryant G et al. Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy. J Clin Oncol 1995; 13:1995–2004.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University Hospital Utrecht, The Netherlands

    Christian W. van Haselen, Johan Toonstra & Willem A. van Vloten

  2. Department of Pathology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands

    Marcel J. Flens, Rik J. Scheper, Paul van der Valk & George L. Scheffer

  3. Department of Dermatology, University Hospital Utrecht, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands

    Christian W. van Haselen

Authors
  1. Christian W. van Haselen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcel J. Flens
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rik J. Scheper
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paul van der Valk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. George L. Scheffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Johan Toonstra
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Willem A. van Vloten
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University Hospital Vrije Universiteit, Amsterdam, The Netherlands

    G. J. L. Kaspers , R. Pieters  & A. J. P. Veerman ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

van Haselen, C.W. et al. (1999). Multidrug Resistance Related Proteins in Primary Cutaneous Lymphomas. In: Kaspers, G.J.L., Pieters, R., Veerman, A.J.P. (eds) Drug Resistance in Leukemia and Lymphoma III. Advances in Experimental Medicine and Biology, vol 457. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4811-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4811-9_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7180-9

  • Online ISBN: 978-1-4615-4811-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation